A Simplified Model of Adenine-Induced Chronic Kidney Disease Using SKH1 Mice

Commonly used adenine-induced chronic kidney disease (CKD) murine models often employ C57BL/6 mice; however, this strain has inherent limitations due to its natural resistance to developing key pathological features of CKD, such as tubulointerstitial fibrosis and inflammation. There have been attemp...

Popoln opis

Bibliografske podrobnosti
Main Authors: Benjamin W. French, Joshua D. Breidenbach, Shereen G. Yassine, Bella Z. Khatib-Shahidi, Sara Kazmi, Caitlin M. Murphy, Humza S. Bashir, Evan M. Benson, Bivek Timalsina, Upasana Shrestha, Dhilhani Faleel, Satkeerth Boyapalli, Prabhatchandra Dube, Apurva Lad, Irum Syed, Deepak Malhotra, Amira Gohara, David J. Kennedy, Steven T. Haller
Format: Article
Jezik:English
Izdano: MDPI AG 2024-12-01
Serija:Cells
Teme:
Online dostop:https://www.mdpi.com/2073-4409/13/24/2117
_version_ 1826917736685502464
author Benjamin W. French
Joshua D. Breidenbach
Shereen G. Yassine
Bella Z. Khatib-Shahidi
Sara Kazmi
Caitlin M. Murphy
Humza S. Bashir
Evan M. Benson
Bivek Timalsina
Upasana Shrestha
Dhilhani Faleel
Satkeerth Boyapalli
Prabhatchandra Dube
Apurva Lad
Irum Syed
Deepak Malhotra
Amira Gohara
David J. Kennedy
Steven T. Haller
author_facet Benjamin W. French
Joshua D. Breidenbach
Shereen G. Yassine
Bella Z. Khatib-Shahidi
Sara Kazmi
Caitlin M. Murphy
Humza S. Bashir
Evan M. Benson
Bivek Timalsina
Upasana Shrestha
Dhilhani Faleel
Satkeerth Boyapalli
Prabhatchandra Dube
Apurva Lad
Irum Syed
Deepak Malhotra
Amira Gohara
David J. Kennedy
Steven T. Haller
author_sort Benjamin W. French
collection DOAJ
description Commonly used adenine-induced chronic kidney disease (CKD) murine models often employ C57BL/6 mice; however, this strain has inherent limitations due to its natural resistance to developing key pathological features of CKD, such as tubulointerstitial fibrosis and inflammation. There have been attempts to overcome these barriers by using multiple concentrations of adenine-supplemented diets or by performing prolonged experiments up to 20 weeks. Here, we demonstrate that SKH1 Elite mice develop clinically relevant CKD phenotypes (e.g., polyuria, proteinuria, inflammation, and renal fibrosis) over the course of only 6 weeks of low-dose (0.15%) adenine supplementation. As a docile, immunocompetent, and hairless strain, SKH1 Elite mice offer several logistical advantages over C57BL/6 mice, including ease of handling and the ability to study dermal conditions, which are often secondary to CKD.
first_indexed 2025-02-17T12:36:51Z
format Article
id doaj.art-a3a3c28f09f9446c8a4e6279a60b15b3
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2025-02-17T12:36:51Z
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-a3a3c28f09f9446c8a4e6279a60b15b32024-12-27T14:16:39ZengMDPI AGCells2073-44092024-12-011324211710.3390/cells13242117A Simplified Model of Adenine-Induced Chronic Kidney Disease Using SKH1 MiceBenjamin W. French0Joshua D. Breidenbach1Shereen G. Yassine2Bella Z. Khatib-Shahidi3Sara Kazmi4Caitlin M. Murphy5Humza S. Bashir6Evan M. Benson7Bivek Timalsina8Upasana Shrestha9Dhilhani Faleel10Satkeerth Boyapalli11Prabhatchandra Dube12Apurva Lad13Irum Syed14Deepak Malhotra15Amira Gohara16David J. Kennedy17Steven T. Haller18Department of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USADepartment of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USADepartment of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USADepartment of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USADepartment of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USADepartment of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USADepartment of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USADepartment of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USADepartment of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USADepartment of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USADepartment of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USADepartment of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USADepartment of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USADepartment of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USADepartment of Medical Microbiology and Immunology, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USADepartment of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USADepartment of Pathology, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USADepartment of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USADepartment of Medicine, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USACommonly used adenine-induced chronic kidney disease (CKD) murine models often employ C57BL/6 mice; however, this strain has inherent limitations due to its natural resistance to developing key pathological features of CKD, such as tubulointerstitial fibrosis and inflammation. There have been attempts to overcome these barriers by using multiple concentrations of adenine-supplemented diets or by performing prolonged experiments up to 20 weeks. Here, we demonstrate that SKH1 Elite mice develop clinically relevant CKD phenotypes (e.g., polyuria, proteinuria, inflammation, and renal fibrosis) over the course of only 6 weeks of low-dose (0.15%) adenine supplementation. As a docile, immunocompetent, and hairless strain, SKH1 Elite mice offer several logistical advantages over C57BL/6 mice, including ease of handling and the ability to study dermal conditions, which are often secondary to CKD.https://www.mdpi.com/2073-4409/13/24/2117chronic kidney disease (CKD)adenine diet modelSKH1 elite micerenal pathologydermatological comorbidities
spellingShingle Benjamin W. French
Joshua D. Breidenbach
Shereen G. Yassine
Bella Z. Khatib-Shahidi
Sara Kazmi
Caitlin M. Murphy
Humza S. Bashir
Evan M. Benson
Bivek Timalsina
Upasana Shrestha
Dhilhani Faleel
Satkeerth Boyapalli
Prabhatchandra Dube
Apurva Lad
Irum Syed
Deepak Malhotra
Amira Gohara
David J. Kennedy
Steven T. Haller
A Simplified Model of Adenine-Induced Chronic Kidney Disease Using SKH1 Mice
Cells
chronic kidney disease (CKD)
adenine diet model
SKH1 elite mice
renal pathology
dermatological comorbidities
title A Simplified Model of Adenine-Induced Chronic Kidney Disease Using SKH1 Mice
title_full A Simplified Model of Adenine-Induced Chronic Kidney Disease Using SKH1 Mice
title_fullStr A Simplified Model of Adenine-Induced Chronic Kidney Disease Using SKH1 Mice
title_full_unstemmed A Simplified Model of Adenine-Induced Chronic Kidney Disease Using SKH1 Mice
title_short A Simplified Model of Adenine-Induced Chronic Kidney Disease Using SKH1 Mice
title_sort simplified model of adenine induced chronic kidney disease using skh1 mice
topic chronic kidney disease (CKD)
adenine diet model
SKH1 elite mice
renal pathology
dermatological comorbidities
url https://www.mdpi.com/2073-4409/13/24/2117
work_keys_str_mv AT benjaminwfrench asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT joshuadbreidenbach asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT shereengyassine asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT bellazkhatibshahidi asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT sarakazmi asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT caitlinmmurphy asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT humzasbashir asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT evanmbenson asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT bivektimalsina asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT upasanashrestha asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT dhilhanifaleel asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT satkeerthboyapalli asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT prabhatchandradube asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT apurvalad asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT irumsyed asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT deepakmalhotra asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT amiragohara asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT davidjkennedy asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT steventhaller asimplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT benjaminwfrench simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT joshuadbreidenbach simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT shereengyassine simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT bellazkhatibshahidi simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT sarakazmi simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT caitlinmmurphy simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT humzasbashir simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT evanmbenson simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT bivektimalsina simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT upasanashrestha simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT dhilhanifaleel simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT satkeerthboyapalli simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT prabhatchandradube simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT apurvalad simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT irumsyed simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT deepakmalhotra simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT amiragohara simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT davidjkennedy simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice
AT steventhaller simplifiedmodelofadenineinducedchronickidneydiseaseusingskh1mice